Brian Adams
Vermögen: 4 Mio $ am 31.07.2026
Vermögen: 4 Mio $ am 31.07.2026
Brian R.
Adams is Secretary & Chief Legal Officer at Kymera Therapeutics, Inc. since 2025.
Formerly, Mr. Adams was Secretary & General Counsel at Relay Therapeutics, Inc. from 2018 to 2022, Secretary, Senior Vice President & General Counsel at Keryx Biopharmaceuticals, Inc. from 2014 to 2018, and General Counsel at Algeta ASA from 2012 to 2014.
Mr. Adams completed undergraduate studies at Harvard University and graduate studies at Columbus School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 226 861 ( 0,1 % ) | 4 Mio $ | 31.07.2026 | |
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | General Counsel | 03.09.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | General Counsel | 13.03.2018 |
| ALGETA ASA | General Counsel | 01.03.2014 |
| RELAY THERAPEUTICS, INC. | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Columbus School of Law
Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen